Tamarappoo B K, Nam M, Kilberg M S, Welbourne T C
Department of Physiology, Louisiana State University Medical Center, Shreveport 71130.
Am J Physiol. 1993 Apr;264(4 Pt 1):E526-33. doi: 10.1152/ajpendo.1993.264.4.E526.
Interorgan glutamine and associated metabolite fluxes were measured across the gut and liver to delineate splanchnic bed fluxes secondary to enhanced arterial loads mobilized in the periphery by glucocorticoid. Experiments were performed on adrenalectomized rats since adrenalectomy doubled the hepatic glucocorticoid receptor population compared with intact animals. Under these conditions, triamcinolone supplement (40 micrograms.day-1.100 g body wt-1) enhanced the combined net glutamine uptake by gut and liver eightfold, whereas combined gut and liver unidirectional breakdown and synthesis fluxes both increased (3.4- and 7.4-fold, respectively). Triamcinolone supplement also altered the pattern of metabolite released; gut released predominantly ammonium and some alanine, whereas the liver removed more alanine along with glutamine and released more urea, glutamate, and glutathione. Mechanistically, enhanced cellular glutamine uptake could be attributed to a three- to fourfold acceleration of glutamine transport associated with a rise in intracellular glutamine content. However, uptake by isolated membrane vesicles revealed only a small (27%) increase in System N activity, whereas extraction and reconstitution of the transporter into proteoliposomes failed to demonstrate increased transporter activity. Similarly, activity of phosphate-dependent glutaminase and glutamate dehydrogenase increased in crude homogenates (2-fold), but the former disappears in completely disrupted preparations. Furthermore, whereas messenger RNA and assayable enzymic activity for glutamate dehydrogenase clearly increased with glucocorticoid, glutaminase message was less significantly increased. Thus glucocorticoid appears directly capable of accelerating hepatic glutamine extraction primarily by modulating transporter activity that is closely coupled to glutamine utilization.
测量了肠道和肝脏之间的器官间谷氨酰胺及相关代谢物通量,以描绘因糖皮质激素动员外周动脉负荷增加而继发的内脏床通量。实验在肾上腺切除的大鼠身上进行,因为与完整动物相比,肾上腺切除术使肝脏糖皮质激素受体数量增加了一倍。在这些条件下,曲安西龙补充剂(40微克·天⁻¹·100克体重⁻¹)使肠道和肝脏的联合净谷氨酰胺摄取增加了八倍,而肠道和肝脏的联合单向分解和合成通量均增加(分别增加了3.4倍和7.4倍)。曲安西龙补充剂还改变了代谢物释放模式;肠道主要释放铵和一些丙氨酸,而肝脏除了摄取谷氨酰胺外还摄取更多丙氨酸,并释放更多尿素、谷氨酸和谷胱甘肽。从机制上讲,细胞谷氨酰胺摄取增加可归因于谷氨酰胺转运加速三到四倍,同时细胞内谷氨酰胺含量增加。然而,分离的膜囊泡摄取显示系统N活性仅小幅增加(27%),而将转运体提取并重组到蛋白脂质体中未能证明转运体活性增加。同样,粗匀浆中磷酸依赖性谷氨酰胺酶和谷氨酸脱氢酶的活性增加了两倍,但在完全破碎的制剂中前者消失。此外,虽然谷氨酸脱氢酶的信使核糖核酸和可检测的酶活性明显随糖皮质激素增加,但谷氨酰胺酶信使核糖核酸的增加不太明显。因此,糖皮质激素似乎直接能够主要通过调节与谷氨酰胺利用密切相关的转运体活性来加速肝脏谷氨酰胺摄取。